We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 67,764

Game-Changing Opinion on Venue from Missouri Supreme Court
  • Reed Smith LLP
  • USA
  • February 15 2019

Bexis is known to say that nothing good ever comes out of Missouri, but the Missouri Supreme Court has proven him wrong. We have long made exceptions


Health Sector Council Released Cybersecurity Recommendations for Medical Devices and Health IT
  • Sidley Austin LLP
  • USA
  • February 14 2019

On January 28, 2019, the Healthcare and Public Health Sector Coordinating Council released the “Medical Device and Health IT Joint Security Plan”


$3 Million Settlement for Two Separate HIPAA Breaches Affecting Over 62,500 Individuals
  • Drinker Biddle & Reath LLP
  • USA
  • February 14 2019

Cottage Health and the Office for Civil Rights at the U.S. Department of Health and Human Services (HHS-OCR) recently entered into a $3 million


Direct To Prescriber Off-Label Communication Ethical Under New AdvaMed Guidelines
  • Reed Smith LLP
  • USA
  • February 14 2019

We’ve been waiting quite a while for the FDA to modernize its positions on the truthful off-label communications by regulated manufacturers. Under


Bipartisan Senate Group Pushes Bill to Protect Patients from Surprise Medical Bills
  • Pepper Hamilton LLP
  • USA
  • February 14 2019

In September 2018, we wrote about a draft U.S. Senate bill aimed to protect patients from surprise medical bills, the "Protecting Patients from


FDA Takes Action on Dietary Supplements Claiming to Treat Alzheimer’s Disease and Other Serious Conditions
  • Keller and Heckman LLP
  • USA
  • February 14 2019

FDA has issued warning letters and online advisories to a number of dietary supplement companies whose products claim to prevent, treat, or cure


FTC and FDA Issue Warning Letters to Supplements Companies
  • Venable LLP
  • USA
  • February 14 2019

Earlier this week, the FTC and the FDA announced a joint effort to combat unsubstantiated health claims in the supplement space. In three warning


The Week in Weed: February 15, 2019
  • Seyfarth Shaw LLP
  • USA
  • February 14 2019

Possibly the biggest news this week was the first ever Congressional hearing on cannabis banking. From the hearing’s webpage, you can watch the


Regulators Look to Increase Interoperability and Patient Access to Health Data
  • Mintz
  • USA
  • February 14 2019

Federal regulators are flexing their regulatory muscle to accelerate a long-desired but often elusive goal: the interoperability of health information


Genetic Testing Company Agrees to Pay $1.99 Million to Resolve Allegations that it Violated the False Claims Act By Billing for Tests Not Covered Under Local Coverage Determinations
  • Epstein Becker Green
  • USA
  • February 14 2019

GenomeDx Biosciences Corp., which markets a genomic test (Decipher) intended to assess the aggressiveness of prostate cancer, has agreed to pay $1